{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-21-020176","form_type":"8-K","ticker":"AVTX","cik":"0001534120","company_name":"Avalo Therapeutics, Inc.","filed_at":"2021-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.940421+00:00","generated_at":"2026-06-28T20:16:56.400235+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Avalo Therapeutics appoints Keith Maher, MD to Board under Armistice Capital right","bullets":["Keith Maher, MD appointed to board effective Oct 15, 2021; term until 2022 annual meeting.","Maher is employed by Armistice Capital Master Fund, a significant stockholder; CIO Steven J. Boyd already on board.","Armistice participated in five offerings since Feb 2020, including 5.45M shares in Sept 2021 offering raising $29.3M net.","Armistice purchased shares in each offering on same terms as other investors."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-21-020176","json":"https://secwatch.observer/filing/0001628280-21-020176.json","markdown":"https://secwatch.observer/filing/0001628280-21-020176.md","text":"https://secwatch.observer/filing/0001628280-21-020176.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534120/000162828021020176/0001628280-21-020176-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534120/000162828021020176/avtx-20211015.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T20:16:56.400235+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5e9bb89629","claim":"Keith Maher, MD was appointed as director at Avalo Therapeutics, Inc..","evidence_excerpt":"On October 15, 2021, the board of directors (the “ Board ”) of Avalo Therapeutics, Inc. (the “ Company ”) appointed Keith Maher, MD, to the Board, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534120/000162828021020176/0001628280-21-020176-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}